3,4-Dihydro-5-Methyl-2H-Pyrrole

Savoury Flavour Modulation and FEMA 3843 Compliance Pathways

3,4-Dihydro-5-methyl-2H-pyrrole (DMHP, CAS 872-32-2) occupies a distinct niche in process flavouring, imparting roasted, nutty, and popcorn-like notes at trace inclusion levels. In spray-dried encapsulated formulations intended for dry soup mixes and extruded snack seasonings, the compound is pre-blended with a carrier matrix of modified starch (OSA-starch E1450) and maltodextrin (DE 10–12) to reduce volatilisation loss during thermal processing. Typical use concentrations in finished foodstuffs fall between 25 and 50 ppb for popcorn applications and 5–15 ppm in savoury baked goods, with exact dosage determined by GC-MS headspace quantification against internal 2-acetyl-1-pyrroline standards. Regulatory compliance requires adherence to FEMA GRAS 3843, the European Union flavourings regulation EC 1334/2008, and the JECFA specification monograph aligning the substance with a purity minimum of 97% by GC. Formulators must avoid combining DMHP with nitrite-containing curing salts or high-alkalinity leavening systems (dough pH > 8.2), as the cyclic imine undergoes hydrolytic ring-opening to 5-amino-2-pentanone derivatives, resulting in rapid flavour fade and the evolution of ammoniacal off-odours.

Production-scale handling of liquid DMHP is complicated by its hygroscopicity and tendency to discolour upon prolonged exposure to headspace oxygen. Closed-loop dosing under nitrogen blanket, coupled with inline static mixers ahead of the spray nozzle assembly, is standard practice in dedicated flavour houses. The compound is often diluted to a 1% stock solution in triacetin (E1518) or propylene glycol (E1520) to facilitate metering accuracy at parts-per-million target levels. When used in retorted canned soups, a two-stage addition protocol is adopted: the DMHP stock is injected post-sterilisation through aseptic ports once the pack temperature drops below 60°C, preserving the thermolabile pyrroline ring. Shelf-life monitoring by accelerated storage at 40°C/75% RH over 12 weeks has demonstrated that encapsulation with a glass-transition temperature (T_g) above 55°C (measured via DSC under ASTM E1356) reduces sensory-perceptible loss by over 30% relative to neat liquid addition. Published data for extended storage beyond 18 months in dry matrix applications are limited, necessitating customer-side validation under site-specific climatic conditions.

In neonicotinoid research programs, the 3,4-dihydro-5-methyl-2H-pyrrole motif serves as a direct entry point to nitromethylene-bridged pharmacophores by Knoevenagel-type condensation with nitromethane. Pilot-scale batches are executed by charging 1.0 molar equivalent of DMHP and 1.15 equivalents of nitromethane into anhydrous methanol (8 volumes w/w) containing 0.05 equivalents of ammonium acetate as catalyst. The exothermic reaction is controlled at 0–5°C using jacketed glass-lined vessels with brine circulation, as thermal excursion above 12°C promotes dimeric by-product formation that is difficult to purge by subsequent fractional distillation. Once the conversion exceeds 95% (tracked by inline FTIR monitoring of the imine absorption at 1660 cm⁻¹), the crude mixture is quenched with 5% aqueous acetic acid and extracted with dichloromethane. Downstream purification via wiped-film short-path distillation at 95°C jacket temperature and 1.5 mbar vacuum yields the nitromethylene intermediate with a purity above 98%. This intermediate is subsequently elaborated into nithiazine analogues and novel cis-nitromethylene neonicotinoids, which proceed to greenhouse screening against hemipteran pests under OECD 213 guidelines. Workers performing the condensation must enforce engineering controls for nitromethane exposure below the OSHA PEL of 100 ppm (8-hour TWA); the DMHP itself is supplied with a REACH-compliant extended safety data sheet covering its skin sensitisation potential (H317) and aquatic toxicity threshold (LC50, 96 h, Danio rerio, > 100 mg/L according to the OECD 203 protocol).

When Optically Active Pyrrolidine Alkaloids Require a Cyclic Imine Entry Point

Enantioselective hydrogenation of 3,4-dihydro-5-methyl-2H-pyrrole opens a convergent route to (S)-nicotine, (S)-nornicotine, and related 2-arylpyrrolidine scaffolds found in CNS-targeted development candidates. The catalytic system most commonly reported at demo scale employs a Ru-BINAP-type complex (0.5 mol% relative to substrate) in degassed methanol under 50 bar hydrogen pressure at 40°C. The reaction is charged into a 316L stainless steel high-pressure autoclave fitted with a hollow-shaft self-inducing impeller operating at 1200 rpm to overcome gas-liquid mass transfer limitations. Optical purity control hinges on strict exclusion of oxygen and water: catalyst pre-activation in a glovebox (O₂ < 5 ppm, H₂O < 1 ppm) and substrate drying over 4 Å molecular sieves to ≤ 200 ppm water content by Karl Fischer titration are mandatory. Under these conditions, the (S)-2-methylpyrrolidine product is isolated with enantiomeric excesses exceeding 98% ee (determined by chiral GC on a β-DEX 225 column) after atmospheric distillation. The hydrogenation protocol is amenable to kilogram-scale operation provided the heat-transfer coefficient of the reactor jacket is sized for an exotherm reaching 35 kJ/mol; failure to maintain isothermal conditions during catalyst injection can erode ee by as much as 12% due to thermal racemisation pathways. For API intermediate applications, residual ruthenium content must be reduced below 10 ppm per ICH Q3D oral concentration limits, achieved through a carbon-adsorption polishing step followed by hot filtration through 0.45 μm PTFE membrane cartridges. All process intermediates prepared under current Good Manufacturing Practice (ICH Q7) additionally require full mass balance reconciliation of the pyrroline starting material, which is characterised by a strong UV chromophore at 230 nm and can be assayed against a qualified external reference standard stored at −20°C in amber glass.

Single-component epoxy systems operating at moderate cure schedules (80–120°C) exhibit a persistent shelf-life/reactivity trade-off that has driven investigation of hydrolytically triggered latent curatives. 3,4-Dihydro-5-methyl-2H-pyrrole, by virtue of its strained cyclic imine bond, remains kinetically dormant in anhydrous epoxy resin matrices yet undergoes moisture-triggered ring-opening to generate a primary aliphatic amine that rapidly crosslinks with oxirane groups. A technical-grade diglycidyl ether of bisphenol A (DGEBA, epoxy equivalent weight 186–190 g/eq) compounded with 5–8 phr of DMHP on a three-roll mill (ceramic rollers, gap setting 15/10 μm) produces a paste that retains pourable viscosity (≤ 60,000 mPa·s at 25°C measured per ISO 3219) for six months when stored in aluminium barrier cartridges. Cure activation is typically conducted in a humidity chamber set to 85% RH and 90°C, yielding full oxirane conversion (confirmed by the disappearance of the epoxide absorbance at 915 cm⁻¹) within 40 minutes. The latency mechanism forces careful preformulation drying of all fillers and thixotropic agents: fumed silica (AEROSIL R 202) must be calcined at 120°C for 4 h prior to dispersion, and any residual moisture above 0.05 wt% (assayed by a Mettler Toledo HX204 halogen moisture analyser) can initiate premature gelation during the milling pass. This constraint effectively prohibits the use of hydrated mineral extenders such as aluminium trihydrate unless the filled system is reformulated as a two-part assembly dispensed through static mixer nozzles.

The table illustrates the inverse relationship between curative loading and latency onset, as well as the property stiffening conferred by higher DMHP content. Process engineers should note that the exothermic peak narrows significantly at the 8 phr level, risking an adiabatic temperature rise inside thick bondlines that can exceed the glass-transition temperature of the partially cured network, creating internal voids. For bondline thicknesses above 2 mm, a stepped cure profile of 80°C for 2 h followed by 100°C for 1 h is implemented to manage enthalpy dissipation.

What Limits Ring-Opening Polymerization of Cyclic Imine Monomers to Low Molecular Weight Oligomers?

DMHP undergoes cationic ring-opening polymerization initiated by methyl tosylate or triethyloxonium tetrafluoroborate (0.5–2.0 mol%) in bulk or concentrated solution, producing oligo(2-methylpyrrolidine) backbones with molecular weights that plateau at M_n 1,500–3,000 g/mol (GPC in water with poly(2-vinylpyridine) calibrants). The kinetic ceiling arises from backbiting and intramolecular transamidation that become kinetically competitive once the monomer conversion surpasses 70%, as evidenced by the appearance of cyclic dimer and trimer peaks in MALDI-TOF spectra. Polymerization performed in N,N-dimethylformamide at 80°C for 24 h under nitrogen typically yields a water-soluble oligomeric amine with a polydispersity index of 1.8–2.4. The crude oligomer, after removal of residual monomer by vacuum stripping at 60°C/2 mbar, shows cationic charge density titrated at pH 4.5 (colloid titration with potassium polyvinyl sulfate), which correlates with its efficacy as a flocculant in kaolin suspension jar tests following ASTM D2035 procedures. Commercial translational efforts focus on exploiting this low-molecular-weight character for temporary wet-strength resins in tissue paper converting, where the poly(2-methylpyrrolidine) is combined with a polyamide-epichlorohydrin synergist at a dry addition ratio of 3:1. The key processing hurdle is the monomer’s susceptibility to inhibitor-dependent induction periods; hydroquinone monomethyl ether (MEHQ, 200 ppm) is incorporated as a stabilizer but must be removed by passage through basic alumina immediately before polymerization to achieve reproducible initiation kinetics.

Chiral Ligand Derivatization via Reductive Amination of the Imine Moiety

The cyclic imine function in DMHP is exploited in the modular construction of bidentate nitrogen ligands for copper- and palladium-catalysed cross-coupling and asymmetric cyclopropanation. In a representative procedure, enantiopure (S)-DMHP (obtained by resolution of the racemate with L-(+)-tartaric acid) is condensed with 2-pyridinecarboxaldehyde under Dean–Stark conditions in toluene to form a diimine intermediate, which is subsequently reduced with sodium triacetoxyborohydride (1.5 eq) in dichloromethane to give an (S)-N-2-picolyl-2-methylpyrrolidine ligand. The overall yield after column chromatography (silica gel 60, 230–400 mesh, eluting with ethyl acetate/methanol/triethylamine 90:5:5) is typically 68–72%. This ligand, when complexed with Cu(OTf)₂ (5 mol%), catalyses asymmetric allylic oxidation of cyclohexene with tert-butyl peroxybenzoate, achieving enantioselectivities of 60–65% ee under reactions monitored by chiral HPLC on a Chiralpak AD-H column. The air-sensitive nature of the free pyrrolidine requires all manipulations to be conducted under an argon atmosphere with glovebox-handled solvents. Stability testing demonstrates that the tosylate salt of the ligand precursor can be stored at ambient temperature for extended periods without racemisation, allowing it to be shipped as a non-hygroscopic crystalline solid per UN38.3 battery of tests for dangerous goods. The reagent’s niche lies in pharmaceutical process chemistry groups exploring enantioselective alkylation paths; published data for scale-up beyond 500 g batch sizes in this specific ligand application remain sparse, and each reaction campaign typically requires reoptimisation of the reductive amination step due to trace metal-sensitive deactivation pathways.

Non-Flavour Heterocycle Feedstock in Agrochemistry: Pyrazole and Triazole Annulation Chemistry

Beyond the direct neonicotinoid route, DMHP functions as a C₄N building block for fused heterocycles with herbicidal and fungicidal activity. Cyclocondensation with hydrazines yields 5,6-dihydro-4H-pyrrolo[1,2-b]pyrazoles, which have been evaluated as acetohydroxyacid synthase (AHAS) inhibitors. A standard laboratory protocol reacts DMHP with methylhydrazine (1.05 eq) in ethanol at reflux for 5 h, followed by oxidation with MnO₂ (3 eq) to aromatise the pyrazole ring, affording a bicyclic scaffold that proceeds to enzymatic assays after flash chromatographic clean-up. The exothermic nature of the hydrazine addition mandates controlled dosing over 45 minutes with the jacket temperature set at −5°C, and the use of vented gas-washing bottles containing 5% aqueous hypochlorite to quench residual hydrazine vapour. Materials produced for field testing must satisfy a purity specification of ≥ 95% area under HPLC at 254 nm, and residual manganese content must be quantified by ICP-OES and limited to < 50 ppm to avoid phytotoxic effects in subsequent glasshouse trials. The commercial viability of this route is linked to the cost-in-use of DMHP relative to acyclic dione precursors, a metric that depends directly on the distillation efficiency of the primary imine recovery step described earlier.